Midway through my recent visit to the Tewksbury office of Thermo Fisher Scientific, my hosts broke the bad news: We don’t have any drugs. Evidently, this was a bring-your-own kind of meeting and no one had told me.
I was at Thermo, to be honest, because it is incredibly hard to understand what this enormous Massachusetts company does. Thermo has 39,000 employees, roughly $13 billion in annual revenues, and a stock you definitely should have bought five or 10 years ago. Yet, unless you wear a white lab coat at work, chances are you don’t run into Thermo’s products — like its $500,000 Q Exactive Hybrid Quadrupole-Orbitrap Mass Spectrometer — very often.